Drugs / Nedaplatin
last change Sep 2026 re-read 8 days ago

Nedaplatin

Small molecule

Developed for
esophageal squamous cell carcinoma · nasopharyngeal carcinoma · non-small cell lung carcinoma · carcinoma of esophagus · esophageal cancer · head and neck squamous cell carcinoma · cervical cancer · squamous cell carcinoma
+12 more · central nervous system neoplasm · combined thymoma · fallopian tube cancer · female breast carcinoma · head and neck cancer · hypopharynx cancer · metastatic malignant neoplasm in the brain · neoplasm · ovarian carcinoma · primary peritoneal carcinoma · tumor of salivary gland · neoplasm of esophagus
Investigated by
Sun Yat-sen University · Chinese Academy of Medical Sciences · Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Zhejiang Cancer Hospital · The First Affiliated Hospital of Guangdong Pharmaceutical University
+60 more · The First Affiliated Hospital of Zhengzhou University · The First Affiliated Hospital with Nanjing Medical University · 303rd Hospital of the People's Liberation Army · Air Force Military Medical University, China · Beijing Friendship Hospital · Cancer Hospital of Guangxi Medical University · Cancer Hospital of Guizhou Province · Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Changhai Hospital · Chinese PLA General Hospital · Fifth Affiliated Hospital, Sun Yat-Sen University · First People's Hospital of Foshan · First People's Hospital of Yulin · Fujian Cancer Hospital · Fuzhou General Hospital · Guangdong Association of Clinical Trials · Guangxi Medical University · Guangxi Naxishan Hospital · Guangxi Traditional Chinese Medical University · Guangzhou Medical University · Guigang People's Hospital · Guilin Medical College · Guiyang Medical University · Hamamatsu University · Harbin Medical University · He Xia · Henan Cancer Hospital · Hunan Cancer Hospital · Jiangsu Cancer Institute & Hospital · Jiangsu HengRui Medicine Co., Ltd. · Jiangsu Simcere Pharmaceutical Co., Ltd. · Jilin Provincial Tumor Hospital · LiuZhou People's Hospital · Liuzhou Cancer Hospital · Liuzhou Hospital of Traditional Chinese Medicine · Liuzhou Railway hospital · Liuzhou Workers' Hospital · Meizhou City Hospital Of Guangdong Provience · Nanning Second People's Hospital · National Natural Science Foundation of China · Peking University · Peking University Cancer Hospital & Institute · People's Hospital of Guangxi Zhuang Autonomous Region · Rongjie Tao · Second Affiliated Hospital of Soochow University · Second Affiliated Hospital, Zhejiang University, School of Medicine · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Tang-Du Hospital · The First Affiliated Hospital of Xiamen University · The Red Cross hospital of YuLin · Third Military Medical University · Tongji Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wigen Biomedicine Technology (Shanghai) Co., Ltd. · Wu Jieping Medical Foundation · Wuzhou Red Cross Hospital · Xiangya Hospital of Central South University · Xijing Hospital · Yuhong Li · Zefen Xiao

Trials 59

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT02964455 Nov 2016 → Dec 2019 esophageal squamous cell carcinoma Sun Yat-sen University Completed No outcome recorded
Phase 1 NCT01175460 Jan 2010 → Jan 2011 esophageal cancer Zhejiang Cancer Hospital Completed No outcome recorded
Phase 1/25 trials
Phase 1/2 NCT06953323 Jul 2025 → Jun 2029 expected neoplasm Wigen Biomedicine Technology (Shanghai) Co., Ltd. Recruiting No outcome recorded
Phase 1/2 NCT06055153 Sep 2023 → Feb 2025 esophageal squamous cell carcinoma Changhai Hospital Unknown No outcome recorded
Phase 1/2 NCT06010212 Aug 2023 → Aug 2025 esophageal squamous cell carcinoma The First Affiliated Hospital with Nanjing Medical University Unknown No outcome recorded
Phase 1/2 NCT05777707 Oct 2020 → Dec 2023 carcinoma of esophagus Beijing Friendship Hospital Unknown No outcome recorded
Phase 1/2 NCT02429622 Jan 2015 → Oct 2016 carcinoma of esophagus Chinese Academy of Medical Sciences Completed No outcome recorded
Phase 237 trials
Phase 2 NCT07843303 Oct 2026 → Sep 2028 expected fallopian tube cancer, ovarian carcinoma, primary peritoneal carcinoma Peking University Cancer Hospital & Institute Not yet recruiting No outcome recorded
Phase 2 NCT07374003 Dec 2025 → Jun 2029 expected — Sun Yat-sen University Active not recruiting No outcome recorded
Phase 2 NCT07046221 Aug 2025 → Aug 2027 expected esophageal squamous cell carcinoma Fujian Cancer Hospital Not yet recruiting No outcome recorded
Phase 2 NCT07019181 Jul → Dec 2025 overdue esophageal squamous cell carcinoma The First Affiliated Hospital of Xiamen University Not yet recruiting No outcome recorded
Phase 2 NCT07284836 Feb 2025 → Jan 2028 expected female breast carcinoma Zhejiang Cancer Hospital Recruiting No outcome recorded
Phase 2 NCT06508229 Jul 2024 → May 2027 expected esophageal squamous cell carcinoma Harbin Medical University Not yet recruiting No outcome recorded
Phase 2 NCT06170697 Mar 2023 → Jul 2024 head and neck squamous cell carcinoma Cancer Institute and Hospital, Chinese Academy of Medical Sciences Unknown No outcome recorded
Phase 2 NCT05880082 Jan 2023 → Aug 2025 esophageal squamous cell carcinoma Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Completed No outcome recorded
Phase 2 NCT05351762 Jul 2022 → May 2024 head and neck squamous cell carcinoma Xijing Hospital Unknown No outcome recorded
Phase 2 NCT05515315 May 2022 → May 2025 overdue — Fuzhou General Hospital Recruiting No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT02279134 Oct 2014 → Dec 2022 esophageal cancer Zefen Xiao Unknown No outcome recorded
Phase 311 trials · 2 met primary
Phase 3 NCT04437329 Aug 2020 → Jun 2028 expected nasopharyngeal carcinoma Affiliated Cancer Hospital & Institute of Guangzhou Medical University Recruiting No outcome recorded
Phase 3 NCT03529279 Jun 2018 → Jun 2026 nasopharyngeal carcinoma Sun Yat-sen University Unknown No outcome recorded
Phase 3 NCT03503136 Jun 2018 → Jun 2024 nasopharyngeal carcinoma Sun Yat-sen University Unknown No outcome recorded
Phase 3 NCT03328234 Sep 2017 → Aug 2021 — Chinese Academy of Medical Sciences Unknown No outcome recorded
Phase 3 NCT01951469 Jan 2016 → Jun 2022 metastatic malignant neoplasm in the brain, non-small cell lung carcinoma Sun Yat-sen University Unknown Met primary
Phase 3 NCT02643407 Oct 2015 → Dec 2017 non-small cell lung carcinoma Guangdong Association of Clinical Trials Unknown No outcome recorded
Phase 3 NCT02607592 Aug 2015 → Jun 2022 non-small cell lung carcinoma Sun Yat-sen University Unknown No outcome recorded
Phase 3 NCT02301208 Dec 2014 → Dec 2016 nasopharyngeal carcinoma He Xia Unknown No outcome recorded
Phase 3 NCT01540136 Feb 2012 → May 2014 nasopharyngeal carcinoma Sun Yat-sen University Completed Met primary
Phase 3 NCT01479504 Nov 2011 → Nov 2012 nasopharyngeal carcinoma Guangxi Medical University Unknown No outcome recorded
Phase 41 trial · 1 missed
Phase 4 NCT02088515 Dec 2013 → Oct 2016 squamous cell carcinoma Jiangsu Simcere Pharmaceutical Co., Ltd. Completed Missed primary
Phase not applicable2 trials
— NCT04174079 Dec 2019 → May 2029 expected esophageal squamous cell carcinoma Sun Yat-sen University Recruiting No outcome recorded
— NCT01201044 Jan 2010 → Sep 2012 non-small cell lung carcinoma Third Military Medical University Unknown No outcome recorded
Comparator or background therapy28 trials
Phase 1/2 NCT01712919 Background May 2010 → Mar 2014 nasopharyngeal carcinoma Jiangsu Cancer Institute & Hospital Completed No outcome recorded
Phase 2 NCT06775275 Background Sep 2024 → Dec 2025 overdue non-small cell lung carcinoma The First Affiliated Hospital of Guangzhou Medical University Recruiting No outcome recorded
Phase 2 NCT06424899 Background May 2024 → May 2027 expected non-small cell lung carcinoma Zeng Jian Recruiting No outcome recorded
Phase 2 NCT06231680 Background Jan → Jun 2024 carcinoma of esophagus, non-small cell lung carcinoma Henan Cancer Hospital Unknown No outcome recorded
Phase 2 NCT05624099 Background Aug 2023 → Dec 2025 overdue neoplasm of esophagus Fujian Cancer Hospital Recruiting No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 89 sources stand behind the page.

FieldValueCited text
Known as Nedaplatin “Patients were randomly assigned to receive 3 cycles of camrelizumab (200 mg) plus chemotherapy (nab-paclitaxel, 130 mg/m2, and platinum [cisplatin, 75 mg/m2; carboplatin, area...” PMID 37535377 ↗ Oct 2023
87

“including but not limited to: Carboplatin + Paclitaxel ± Bevacizumab, Carboplatin + Pegylated Liposomal Doxorubicin ± Bevacizumab, or Carboplatin + Gemcitabine ± Bevacizumab;...” NCT07843303 ↗

“pemetrexed 500mg/m2 combined with cisplatin 75mg/m2 or nedaplatin 80mg/m2 intravenously on day 1 of each 3-week cycle for four to six cycles, followed by pemetrexed maintenance...” NCT01951482 ↗

“Tislelizumab 200mg, Q3W, 2-4 cycles Albumin paclitaxel 240 mg/m², adjusted according to the patient Carboplatin: AUC=5 Q3W, d1 or cisplatin: 20mg/m² iv, D1-3 Q3W or Nedaplatin:...” NCT05880082 ↗

“Low-dose of Nedaplatin (CDGP) 10 mg/body/day was daily administered on day 1-5, 8-13, 15-19, 22-26 and 5-FU 500 mg/body/day was continuously administered on day 1-5, 8-13, 15-19, 22-26.” NCT00197444 ↗

“Esophageal squamous cell carcinoma: cisplatin/carboplatin/nedaplatin/lobaplatin+ paclitaxel/albumin-bound paclitaxel/fluorouracil on Day 1 of each 21-day cycle for 4-6 cycles;” NCT06231680 ↗

“All patients received weekly docetaxel(25mg/㎡) and nedaplatin or cisplatin (25mg/㎡), each of 1 day's duration, concurrently with hypofractionated radiotherapy .” NCT03663764 ↗

“paclitaxel or albuminotaxol or docetaxel combined with platinum, pemetrexed combined with platinum. Platinums include carboplatin, cisplatin and nedaplatin.” NCT06775275 ↗

“Patients received 2-3 cycles of neoadjuvant therapy with camrelizumab, nedaplatin, albumin paclitaxel, and apatinib; each cycle was repeated every 14 days.” PMID 38618203 ↗ Apr 2024

“Concurrent chemotherapy, 5-Fu + nedaplatin (cisplatin), every 28 days; 5-Fu 500mg/m2. D, civ d1-d5, nedaplatin (cisplatin) 80mg (70mg) /m2.” NCT03529279 ↗

“Chemotherapy with cisplatin or nedaplatin (both 80-100mg/m2, 21 day per cycle, 1-3 cycles) is used or not concurrent with radiotherapy.” NCT03101514 ↗

Show 77 more sources

Known as Aqupla ChEMBL registry synonym — accepted as the source's own label CHEMBL3137685 ↗
Known as CDGP “Low-dose of Nedaplatin (CDGP) 10 mg/body/day was daily administered on day 1-5, 8-13, 15-19, 22-26 and 5-FU 500 mg/body/day was continuously administered on day 1-5, 8-13, 15-19, 22-26.” NCT00197444 ↗
Known as cis-diammine-glycolatoplatinum “We evaluated the efficacy and the toxicity of a novel regimen of daily low-dose nedaplatin (cis-diammine-glycolatoplatinum) and continuous infusion of 5-fluorouracil (5-FU)...” PMID 19930599 ↗ Nov 2009
Known as NDP “Chemotherapy: Nedaplatin(NDP) 30-40mg/m2 iv., on day1, 4weeks as one cycle” NCT02835404 ↗
Known as Nedaplatine ChEMBL registry synonym — accepted as the source's own label CHEMBL3137685 ↗
Known as Nedaplatino ChEMBL registry synonym — accepted as the source's own label CHEMBL3137685 ↗
Known as NSC-375101D ChEMBL registry synonym — accepted as the source's own label CHEMBL3137685 ↗
Modality Small molecule “Nedaplatin is a second-generation platinum compound” NCT02088515 ↗
Route Intravenous “IV drip on day 1 of each 21 day cycle” NCT01137123 ↗